Opening Remarks: Twenty years of supporting pediatric research: from unmet needs to future priorities
The opening session marked 20 years of TEDDY Network’s contribution to paediatric research in Europe. Donato Bonifazi, Chair of TEDDY Network, presented the network’s key achievements, highlighting its role in addressing evidence gaps, strengthening collaboration across the paediatric research community, advancing research methodologies and promoting the meaningful involvement of children and young people. The presentation also explored persistent challenges and future priorities for improving the quality, ethics and sustainability of paediatric research.
Donato Bonifazi
Read more
Donato Bonifazi is an Economist and the Chair of TEDDY – European Network of Excellence for Paediatric Clinical Research, which started as an FP6 funded Network of Excellence in 2005. He has been CEO of CVBF – Clinical Validation from Biopharmaceutical Findings, a non-profit research consortium with 25 years’ experience in health and pharmaceutical research, as a Sponsor or a Partner/CRO in clinical research, until January 2026.
He is also Member of: the Coordinating Group at Enpr-EMA, the ACT EU multi- stakeholder platform Advisory Group, the international Children Advisory Network ( iCAN ) Advisory Board, the AICRO Board of Directors, the EUCROF Paediatric WG, the EFGCP Paediatric Medicines WG, the IRDiRC patient engagement WG, and Chair of the TEDDY WG on Children Engagement and Advocacy
He is involved in several projects aimed at enhancing research for paediatric and rare diseases patients (i.e. OrphaDev4Kids aimed to foster the development of paediatric medical devices, ERDERA the EU Rare Disease Research Partnership, ERAMET and INVENTS, aimed at developing innovative trial methodologies for unmet needs) and is Coordinator of EPTRI (European Paediatric Translational Research Infrastructure) aimed to enhance technology-driven paediatric research in drug discovery and early development phases to be translated into clinical research and paediatric use of medicines, diagnostics and devices.
He has been Trial Leader of two EU-funded multinational paediatric clinical trials between 2011–2017 and project coordinator of the EU-funded project DEEP – DEferiprone Evaluation in Paediatrics (FP7 GA 241683), involving 32 clinical centers from European and Mediterranean countries, and also involved in relevant groups/projects/platforms aimed at enhancing clinical trials for paediatric and rare diseases patients: WP3 Leader within PedCRIN – Paediatric Clinical Research Infrastructure Network (H2020 GA 731046); c4c – Network for European Clinical Trials for Children (H2020 GA 777389); EJP RD – European Joint Programme on Rare Diseases (H2020 GA 825575).